Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Quaking Regulates Neurofascin 155 Expression for Myelin and Axoglial Junction Maintenance.
Microglia regulate hippocampal neurogenesis during chronic neurodegeneration.
Similar barriers and facilitators to physical activity across different clinical groups experiencing lower limb spasticity.
Urodynamics in the Evaluation of the Patient with Multiple Sclerosis: When Are They Helpful and How Do We Use Them?
Ultrasound of inherited vs. acquired demyelinating polyneuropathies.
Multiple sclerosis: IL-12p40-an early biomarker for multiple sclerosis?
Increased frequency and severity of restless legs syndrome in patients with neuromyelitis optica spectrum disorder.
Erratum to: Reassessing the risk of natalizumab-associated PML.
Comparative Neuroregenerative Effects of C-Phycocyanin and IFN-Beta in a Model of Multiple Sclerosis in Mice.
Protoporphyrin Treatment Modulates Susceptibility to Experimental Autoimmune Encephalomyelitis in miR-155-Deficient Mice.
Annotation of functional variation within non-MHC MS susceptibility loci through bioinformatics analysis.
Socio-economic factors and immigrant population studies of multiple sclerosis.
MRI-based diagnostic biomarkers for early onset pediatric multiple sclerosis.
Persistent Headache in Patients With Multiple Sclerosis Starting Treatment With Fingolimod.
Defective Autoimmune Regulator-Dependent Central Tolerance to Myelin Protein Zero Is Linked to Autoimmune Peripheral Neuropathy.
Ozone Therapy in Ethidium Bromide-Induced Demyelination in Rats: Possible Protective Effect.
Crosstalk between endocannabinoid and immune systems: a potential dysregulation in depression?
Disease-modifying treatments for multiple sclerosis - a review of approved medications.
Environmental enrichment as a method to improve cognitive function. What can we learn from animal models?
Retinal nerve fiber layer thickness and neurologic disability in relapsing-remitting multiple sclerosis.
New evidence for teriflunomide in multiple sclerosis.
The Significance of Matrix Metalloproteinases in the Immunopathogenesis and Treatment of Multiple Sclerosis.
▼Teriflunomide for multiple sclerosis.
Non-myeloablative autologous haematopoietic stem cell transplantation expands regulatory cells and depletes IL-17 producing mucosal-associated invariant T cells in multiple sclerosis.
Gait characteristics of multiple sclerosis patients in the absence of clinical disability.
Pages
« first
‹ previous
…
695
696
697
698
699
700
701
702
703
…
next ›
last »